Back to search

Article

Relapse timing is associated with distinct evolutionary dynamics in DLBCL

2023-03-08

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL) is cured in over 60% of patients, but outcomes are poor for patients with relapsed or refractory disease (rrDLBCL). Here, we performed whole genome/exome sequencing (WGS/WES) on tumors from 73 serially-biopsied patients with rrDLBCL. Based on the observation that outcomes to salvage therapy/autologous stem cell transplantation are related to time-to-relapse, we stratified pati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7c7749cc-5ff0-5427-8eb8-b4fcf72cd2bc
DOI
10.1101/2023.03.06.23286584
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Relapse timing is associated with distinct evolutionary dynamics in DLBCLDOI 10.1101/2023.03.06.23286584
Select a neighboring publication to make it the new centre.